BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23160206)

  • 1. HOIL and water: the two faces of HOIL-1 deficiency.
    Ombrello MJ; Kastner DL; Milner JD
    Nat Immunol; 2012 Dec; 13(12):1133-5. PubMed ID: 23160206
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.
    Boisson B; Laplantine E; Prando C; Giliani S; Israelsson E; Xu Z; Abhyankar A; Israël L; Trevejo-Nunez G; Bogunovic D; Cepika AM; MacDuff D; Chrabieh M; Hubeau M; Bajolle F; Debré M; Mazzolari E; Vairo D; Agou F; Virgin HW; Bossuyt X; Rambaud C; Facchetti F; Bonnet D; Quartier P; Fournet JC; Pascual V; Chaussabel D; Notarangelo LD; Puel A; Israël A; Casanova JL; Picard C
    Nat Immunol; 2012 Dec; 13(12):1178-86. PubMed ID: 23104095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update on Autoinflammatory Diseases: Relopathies.
    Steiner A; Harapas CR; Masters SL; Davidson S
    Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination.
    Elton L; Carpentier I; Verhelst K; Staal J; Beyaert R
    Immunol Rev; 2015 Jul; 266(1):208-21. PubMed ID: 26085217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.
    Boisson B; Laplantine E; Dobbs K; Cobat A; Tarantino N; Hazen M; Lidov HG; Hopkins G; Du L; Belkadi A; Chrabieh M; Itan Y; Picard C; Fournet JC; Eibel H; Tsitsikov E; Pai SY; Abel L; Al-Herz W; Casanova JL; Israel A; Notarangelo LD
    J Exp Med; 2015 Jun; 212(6):939-51. PubMed ID: 26008899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency.
    Oda H; Manthiram K; Chavan PP; Rieser E; Veli Ö; Kaya Ö; Rauch C; Nakabo S; Kuehn HS; Swart M; Wang Y; Çelik NI; Molitor A; Ziaee V; Movahedi N; Shahrooei M; Parvaneh N; Alipour-Olyei N; Carapito R; Xu Q; Preite S; Beck DB; Chae JJ; Nehrebecky M; Ombrello AK; Hoffmann P; Romeo T; Deuitch NT; Matthíasardóttir B; Mullikin J; Komarow H; Stoddard J; Niemela J; Dobbs K; Sweeney CL; Anderton H; Lawlor KE; Yoshitomi H; Yang D; Boehm M; Davis J; Mudd P; Randazzo D; Tsai WL; Gadina M; Kaplan MJ; Toguchida J; Mayer CT; Rosenzweig SD; Notarangelo LD; Iwai K; Silke J; Schwartzberg PL; Boisson B; Casanova JL; Bahram S; Rao AP; Peltzer N; Walczak H; Lalaoui N; Aksentijevich I; Kastner DL
    Nat Immunol; 2024 May; 25(5):764-777. PubMed ID: 38609546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
    Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
    FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment.
    Ochs HD; Hagin D
    Ann Allergy Asthma Immunol; 2014 Jun; 112(6):489-95. PubMed ID: 24860921
    [No Abstract]   [Full Text] [Related]  

  • 9. The paracaspase MALT1 dampens NF-κB signalling by cleaving the LUBAC subunit HOIL-1.
    Hailfinger S; Schmitt A; Schulze-Osthoff K
    FEBS J; 2016 Feb; 283(3):400-2. PubMed ID: 26716947
    [No Abstract]   [Full Text] [Related]  

  • 10. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
    Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
    J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex.
    Sato Y; Fujita H; Yoshikawa A; Yamashita M; Yamagata A; Kaiser SE; Iwai K; Fukai S
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20520-5. PubMed ID: 22139374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection.
    MacDuff DA; Reese TA; Kimmey JM; Weiss LA; Song C; Zhang X; Kambal A; Duan E; Carrero JA; Boisson B; Laplantine E; Israel A; Picard C; Colonna M; Edelson BT; Sibley LD; Stallings CL; Casanova JL; Iwai K; Virgin HW
    Elife; 2015 Jan; 4():. PubMed ID: 25599590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HOIL-1L ligase modulates immune signalling and cell death via monoubiquitination of LUBAC.
    Fuseya Y; Fujita H; Kim M; Ohtake F; Nishide A; Sasaki K; Saeki Y; Tanaka K; Takahashi R; Iwai K
    Nat Cell Biol; 2020 Jun; 22(6):663-673. PubMed ID: 32393887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.
    Bousfiha A; Jeddane L; Picard C; Al-Herz W; Ailal F; Chatila T; Cunningham-Rundles C; Etzioni A; Franco JL; Holland SM; Klein C; Morio T; Ochs HD; Oksenhendler E; Puck J; Torgerson TR; Casanova JL; Sullivan KE; Tangye SG
    J Clin Immunol; 2020 Jan; 40(1):66-81. PubMed ID: 32048120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease.
    Beck DB; Aksentijevich I
    Front Immunol; 2019; 10():101. PubMed ID: 30766537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation.
    Tokunaga F; Sakata S; Saeki Y; Satomi Y; Kirisako T; Kamei K; Nakagawa T; Kato M; Murata S; Yamaoka S; Yamamoto M; Akira S; Takao T; Tanaka K; Iwai K
    Nat Cell Biol; 2009 Feb; 11(2):123-32. PubMed ID: 19136968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monogenic autoinflammatory disorders: beyond the periodic fever.
    Moghaddas F
    Intern Med J; 2020 Feb; 50(2):151-164. PubMed ID: 31260149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunology 2010].
    Behrens GM; Schmidt RE
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1312-4. PubMed ID: 20556689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.